Mesh Bio Overview

  • Year Founded
  • 2018

Year Founded

  • Status
  • Private

  • Employees
  • 27

Employees

  • Latest Deal Type
  • Series A

  • Latest Deal Amount
  • $4.55M

  • Investors
  • 13

Mesh Bio General Information

Description

Developer of a multidimensional health intelligence platform designed to transform chronic disease management through predictive analytics. The company's platform automates health screening report generation, increases accuracy, helps to understand the implications of laboratory reports, and offers holistic patient assessment, enabling healthcare providers to manage patients' health, lifestyle, and disease risks.

Contact Information

Website
www.meshbio.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 22 Sin Ming Lane
  • Suite 07-83 Midview City
  • Singapore, 573969
  • Singapore
+65 9336
Primary Industry
Decision/Risk Analysis
Other Industries
Outcome Management (Healthcare)
Vertical(s)
Corporate Office
  • 22 Sin Ming Lane
  • Suite 07-83 Midview City
  • Singapore, 573969
  • Singapore
+65 9336

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Mesh Bio Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Later Stage VC (Series A) 30-Jan-2024 $4.55M Completed Generating Revenue
3. Seed Round 18-Apr-2021 Completed Generating Revenue
2. Accelerator/Incubator 31-Oct-2019 Completed Startup
1. Accelerator/Incubator Completed Startup
To view Mesh Bio’s complete valuation and funding history, request access »

Mesh Bio Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A
Seed
To view Mesh Bio’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Mesh Bio Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a multidimensional health intelligence platform designed to transform chronic disease management through pr
Decision/Risk Analysis
Singapore, Singapore
27 As of 2026

San Diego, CA
 

Nashville, TN
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Mesh Bio Competitors (2)

One of Mesh Bio’s 2 competitors is ForeSee Medical, a Venture Capital-Backed company based in San Diego, CA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
ForeSee Medical Venture Capital-Backed San Diego, CA
Decode Health Venture Capital-Backed Nashville, TN
You’re viewing 2 of 2 competitors. Get the full list »

Mesh Bio Patents

Mesh Bio Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-4326144-A1 Method and system for generating a metabolic digital twin for clinical decision support Pending 20-Apr-2021
EP-4326144-A4 Method and system for generating a metabolic digital twin for clinical decision support Pending 20-Apr-2021
US-20240212851-A1 Method and system for generating a metabolic digital twin for clinical decision support Pending 20-Apr-2021
WO-2022225460-A1 Method and system for generating a metabolic digital twin for clinical decision support Inactive 20-Apr-2021 G16H10/60

Mesh Bio Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Mesh Bio Investors (13)

Investor Name Investor Type Holding Investor Since Participating Rounds
East Ventures Venture Capital Minority
Elev8 Venture Partners Growth/Expansion Minority
Mitsui & Co., Ltd Corporation Minority
Plug and Play Accelerator/Incubator Minority
Angel (individual) Minority
You’re viewing 5 of 13 investors. Get the full list »

Mesh Bio FAQs

  • When was Mesh Bio founded?

    Mesh Bio was founded in 2018.

  • Where is Mesh Bio headquartered?

    Mesh Bio is headquartered in Singapore, Singapore.

  • What is the size of Mesh Bio?

    Mesh Bio has 27 total employees.

  • What industry is Mesh Bio in?

    Mesh Bio’s primary industry is Decision/Risk Analysis.

  • Is Mesh Bio a private or public company?

    Mesh Bio is a Private company.

  • What is the current valuation of Mesh Bio?

    The current valuation of Mesh Bio is .

  • What is Mesh Bio’s current revenue?

    The current revenue for Mesh Bio is .

  • How much funding has Mesh Bio raised over time?

    Mesh Bio has raised $6.95M.

  • Who are Mesh Bio’s investors?

    East Ventures, Elev8 Venture Partners, Mitsui & Co., Ltd, Plug and Play, and are 5 of 13 investors who have invested in Mesh Bio.

  • Who are Mesh Bio’s competitors?

    ForeSee Medical and Decode Health are competitors of Mesh Bio.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process